Liven Pharma Ltd · PSX:LIVEN
Liven Pharma — Investor Presentation (2024)
20 slides from Liven Pharma's investor presentation, 2024
Slide 1: Liven Pharma Limited Corporate Briefing Session
LIVEN PHARMA LIMITED LIVE WITH HEALTH Presentation Corporate Briefing Session 4 9 , K M L A H O R E M U L T A N R O A D W W W . L I V E N - P H A R M A . C O M + 9 2 ( 3 ) 1 1 1 0 L I V E N
Slide 2: Table of Content
Table of Content Company Profile……………………………………03 Liven standing in Market…………………………..13 Corporate Information………………...………….04 Industry growth Dynamics………………………..15 Board of Directors……………….…………………05 Financial Highlights……………..…………………..16 Vision and Mission Values……………………….06 Key Brands……………………………...
Slide 3: Company Profile
Company Profile We strive to create the company of the future. We believe that manufacturing medicine is not only a business but a duty, Liven Pharma Ltd is the way forward and is going to be the gateway of the Pakistan’s Pharmaceutical sector, we are guided and inspired by our vision of future, her
Slide 4: Corporate Information
Corporate Information SHARE HOLDER’S CATEGORY SHAREHOLDING PERCENTAGE Sponsors 86.8 % Individuals 3.53% Free Float 5% Physical 4.67% Liven Pharma Limited (formerly Landmark Spinning Industries Limited) was incorporated in Pakistan as a private Limited Company on October 21, 1991 and was converted in
Slide 5: Boards of Directors
Boards of Directors Non Executive Director Director Firdous Mr. Umar Shakir Mujeeb Shami Independent Chairman Board CEO Director Mr. Atif Hussain Mr. Kaashif Mr. Syed Hussain Non Raza Abbas Executive Independent Director Director Mr. Usman Mr. Shoaib Mujeeb Hashmi Shami
Slide 6: Vision and Mission
Vision and Mission Vision: Our business focus made explicit in this plan, renews our vision and strategic thinking on adding value to our target market segments. From average buyer to high-end institutions we will position ourselves in a manner to differentiate us from box pushers to serious minded
Slide 7: Our Core Business Areas
Our Core Business Areas TABLETS Antibiotics CAPSULES Anti inflammatory Proton Pump Anti Cancer Inhibitors (PPI) Anti Histamine Antidepressant Non Steroidal INJECTABLES Anti Inflammatory Anti Histamine Anti Psychotic NSAID Anti Emetic Anti Fungal Anti Spasmodic INFUSIONS Anti Biotic Anti Biotic Analg
Slide 8: Liven Pharma Ltd 2024
In October 2015, LIVEN was formed through the LIVEN incorporation as a private limited company, with a mission to help people worldwide to live healthier PHARMA and better in every stage of life. LTD 2024 For nearly 24 years, the sponsors of LIVEN are in directly or indirectly involved in the pharma
Slide 9: Manufacturing Facility
Welcome to the world of Health and Wealth Injectable General Capsules 95600 Square feet of occupied land Injectable Psychotropic 28500 Square feet of manufacturing and utilities facility More than 100 products Active in Global Scale Tablets Infusion Vials Manufacturing Facility Sachets Making Legacy
Slide 10: Product Launch Journey
Product Launch Journey Our Journey Start in October 2018 2025 2024 Livair Tab Mectate Sachet Alset Tab 2023 Tramox Plus Tab Esci Tab Tramadol Inj PTNOL Inj 2022 Re-leef Sachet Fluconazole Inf Citicoline inj 2021 Fluconazole Caps Nalbuphine inj Renoval Tab 2020 Renoval Inf Atavast Tab Diazepam Inj Pe
Slide 11: Our Global Presence
Our Global Presence Sri Lanka Uzbekistan Yemen Our Reach Beyond the Borders Cambodia Having a significant presence Afghanistan and reaching towards a new destinations Vietnam Exports Kazakhstan Road to Export
Slide 12: Pakistan Pharma Overview
Pakistan Pharma overview 40 Billion and Above Pakistan Pharma Overview Value 277 Billion Market Share Figures provided are in PKR (Billions) 30.19% 1400 1200 1000 10 Billion and Above 800 600 5 Billion and Above 400 200 0 2023 2024 2025 2026 MNCs LOCAL
Slide 13: Liven Standing In Market
Liven Standing In Market 653 KETOROLAC 1,894,749,532 19,778.84 TORADOL TORAD MD. 1,116,486,391 658.75 TEKAC TEKAC SAM 112,815,848 539.75 KETRODIL KETRO ICI 102,118,957 762.97 KETOROGET KETOR GTZ 78,661,256 637.50 9,851,079,8 194 COLECALCIFEROL 09 64,303.14 2,891,972,4 INDRO INDROP-D N/P 55 1,558.90
Slide 14: Liven Standing In Market
Liven Standing In Market Paracetamol Infusion 2,746,001,525 PROVAS 165 SAM 1,083,860,528 7,016,081 BOFALGAN 101 B6H 1,583,580,888 10,201,971 PARACET 1918 STH 67,819,000 684,183 CETOZEK 20 4536 BI- 10,741,109 62,541 ROSUVASTATIN 8,007,758,527 21,632,913 ROVISTA 39 GTZ 2,849,366,687 3,764,533 OMNITOR
Slide 15: Industry Growth Dynamics
Industry Growth Dynamics 2024 Market Size 1712 Million U$D 2026 Expected Growth 2980 Million 2025 U$D Expected Market Size 2469 Million U$D Data Source Statisca and Google Research AI
Slide 16: Financial Highlights
Financial Highlights Particulars Standalone PKR Million 30th Sep 2024 Sales 88,909,727 Gross Profit 24,810,923 Gross Margin 27.90 % Operating Profit Profit After Tax 20,415,920 EPS 510
Slide 17: Key Brands
Pharma Limited. G BuB DO Key Brands AMD iit: AMD2i: [(\zithromy in) as my Tramoy | Awe An Tramadol HCI G) vu (19) 1) (20 t (40) H if i (28 it -_ frecs sy ast) [Aiv2st Vit_-B Injection yicBss" (Vitamin B.+ B.+ B.) De [a3] Livazole (Letrozole) — ©
Slide 18: ff [EN
ff [EN EES Pharma Limited. ‘mi x 5 Ampoules Live With Health EsopROz Esoproz (EEOREETRTOIST [ll (Esomeprazole) ‘ BIGOFURe=am 5E 3 Iron Sucrose Injection E i aa USP 100mg/5ml S34 Levon’<. “Levon 4: : Mi ED yy j rae aD 7 if 5 Ciprolab gay (Ciprofloxacin) © LA » cLosop (Diclofe: 75
Slide 19: SOT Analysis
SOT Analysis Strengths: Strong Research and Development: Experienced Management Team: Opportunities: Wide Product Portfolio: Growing Demand for Pharmaceuticals: Strong Distribution Network: . Emerging Markets: Expansion in the API Threats: Market: Regulatory Changes: Expansion in
Slide 20: Future Outlook
Future Outlook Liven Pharma Limited is a leading pharmaceutical company that is poised for significant growth and innovation in the coming years. With a strong foundation in research and development, manufacturing, sales and marketing, the company is well- Significant Growth positioned to capitali